Empagliflozin first antidiabetes drug to gain cardioprotective indicationDecember 2, 2016DiabetesCardiology
New guidelines provide standardized hypoglycemia values for clinical evaluationDecember 1, 2016DiabetesEndocrinology
New PAD guidelines expected to boost awareness and treatmentDecember 1, 2016DiabetesClinical Guidelines
Diabetes drugs with cardiovascular benefits broaden cardiology’s turfNovember 9, 2016CardiologyDiabetesEndocrinology
Continuous glucose monitoring recommended over finger sticks for type 1 diabetesOctober 1, 2016Diabetes
Genes that drive glucose levels also drive heart diseaseSeptember 30, 2016DiabetesCardiologyEndocrinology
CABG best for diabetes patients with CKD – or is it?September 27, 2016DiabetesCardiologyEndocrinologyNephrology
Aspirin not prescribed appropriately to cut cardiovascular risk in diabetesSeptember 27, 2016CardiologyDiabetesEndocrinologyThrombosis
Insulin-dependent pilots can fly safely with glucose monitoring protocolSeptember 14, 2016DiabetesEndocrinology
Brain atrophy is already evident in patients with prediabetesSeptember 14, 2016DiabetesEndocrinologyNeurology
